High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure
The Clinical Respiratory Journal Feb 07, 2018
Lee MK, et al. - Two management strategies for severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) were compared herein viz high flow nasal cannulae (HFNC) therapy vs non-invasive ventilation (NIV). In this prospective observational trial, it was shown that both HFNC and NIV afforded no different 30-day mortality and intubation rate.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
